...
首页> 外文期刊>The Journal of craniofacial surgery >Use of hydroxyapatite cement in pediatric craniofacial reconstructive surgery: strategies for avoiding complications.
【24h】

Use of hydroxyapatite cement in pediatric craniofacial reconstructive surgery: strategies for avoiding complications.

机译:羟基磷灰石水泥在小儿颅面重建手术中的应用:避免并发症的策略。

获取原文
获取原文并翻译 | 示例

摘要

The emergence of powdered hydroxyapatite (HA) has dramatically expanded the repertoire of reconstructive tools for craniofacial surgeons. Although several groups have reported mixed success using HA powder, to date there have been few large series retrospective reviews of HA use in an exclusively pediatric population. The purpose of our study was to assess the incidence of complications using a single surgeon's experience in an entirely pediatric cohort of patients. We present 78 pediatric patients (mean age, 9 [SD, 5.1] years; 26 girls, 52 boys) who have undergone craniofacial reconstruction with HA powder in the form of Mimix or BoneSource (mean, 57.3 [SD, 27.9] g). From this cohort, we discuss in detail 7 patients who experienced complications after their reconstruction with HA. These complications were related to trauma, infection, and exposure. Of these 7 patients with problems, 6 required eventual HA removal. In addition, all 7 patients who had complications after HA reported having a traumatic event with respect to their cranial reconstruction before presenting with a complication. Our series concludes that HA powder is a safe and effective material for use in pediatric craniofacial reconstruction. When certain principles are not violated, meticulous hemostasis and surgical planning are of paramount importance to reduce the incidence of seroma, exposure, and infection of the overlying HA placement. However, should these complications arise, prompt removal of HA is usually necessary.
机译:粉末状羟基磷灰石(HA)的出现极大地扩展了颅面外科医生的重建工具的种类。尽管有几组报告使用HA粉末取得了不同的成功,但迄今为止,很少有专门针对儿科人群使用HA的大型系列回顾性回顾。我们研究的目的是使用单个外科医生在整个儿科患者队列中的经验来评估并发症的发生率。我们介绍了78位儿科患者(平均年龄,9 [SD,5.1]岁; 26位女孩,52位男孩),他们接受了以Mimix或BoneSource形式的HA粉末进行颅面重建术(平均57.3 [SD,27.9] g)。从这个队列中,我们详细讨论了7例HA重建后出现并发症的患者。这些并发症与创伤,感染和接触有关。在这7名有问题的患者中,有6名需要最终清除HA。此外,所有7例在HA后出现并发症的患者均报告称,​​在出现并发症之前,其颅骨重建发生了创伤事件。我们的系列结论认为,HA粉是用于儿科颅面重建的安全有效材料。当不违反某些原则时,进行细致的止血和手术计划对于减少血清瘤,暴露和上覆HA放置的感染率至关重要。但是,如果出现这些并发症,通常必须迅速清除HA。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号